SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-060095
Filing Date
2011-11-02
Accepted
2011-11-02 16:37:33
Documents
12
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a11-25641_110q.htm 10-Q 1094334
2 EX-10.54 a11-25641_1ex10d54.htm EX-10.54 59749
3 EX-10.55 a11-25641_1ex10d55.htm EX-10.55 63274
4 EX-31.1 a11-25641_1ex31d1.htm EX-31.1 12995
5 EX-31.2 a11-25641_1ex31d2.htm EX-31.2 13704
6 EX-32 a11-25641_1ex32.htm EX-32 11451
  Complete submission text file 0001104659-11-060095.txt   3877358

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT thrx-20110930.xml EX-101.INS 566017
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT thrx-20110930.xsd EX-101.SCH 12578
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT thrx-20110930_cal.xml EX-101.CAL 35606
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT thrx-20110930_lab.xml EX-101.LAB 189990
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT thrx-20110930_pre.xml EX-101.PRE 96668
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT thrx-20110930_def.xml EX-101.DEF 65983
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 111174905
SIC: 2834 Pharmaceutical Preparations